Advanced Healthcare Materials, Journal Year: 2025, Volume and Issue: unknown

Published: April 27, 2025

Abstract Molybdenum disulfide (MoS₂) nanomaterials have attracted significant interest in cancer diagnosis and therapy due to their unique physicochemical properties. Due its extensive surface area adaptable structure, MoS₂ may engage with pharmaceuticals biomolecules via covalent non‐covalent interactions. This versatility enhances the sensitivity of identifying specific biomarkers, colloidal stability, tumor‐targeting capabilities. In near‐infrared (NIR) spectrum, exhibits strong optical absorption efficient photothermal conversion, making it suitable for NIR‐driven phototherapy regulated medication release. Functionalized nanocomposites react differently tumor microenvironment, which improves treatment effectiveness by increasing drug accumulation at sites decreasing off‐target effects on healthy tissues. Recent developments MoS₂‐based detection are reviewed this study, particular attention paid uses therapy, photodynamic biosensing, bioimaging. Additionally, looks difficulties potential applications cancer.

Language: Английский